A Catalyst for Innovation

The State and Indiana’s leading life sciences companies, academic research universities and medical school, and philanthropic community saw the need for better health solutions in the local and global community and called for the creation of the IBRI.

Few places can match the depth and scale of complementary life sciences research and development activities that occur in Indiana. By leveraging and building on existing industry and academic expertise in nutrition science, genetics and genomics, biochemistry, endocrinology, novel delivery systems and therapeutic approaches, the IBRI will deliver important answers to metabolic disease. Metabolic disease, including diabetes, cardiovascular disease, and obesity, and poor nutrition are global epidemics with significant health, quality of life and economic impacts.

The IBRI’s mission is to become the leading independent, industry-inspired applied research institute in the discovery and development of innovative solutions to improve health, targeting diabetes, metabolic disease and poor nutrition.

Our goals:

The IBRI was created as an honest broker to eliminate barriers and foster team science. We bring partners together to accelerate research and find solutions faster than ever before for the people of Indiana and beyond. Our motto, Discovery With Purpose, reflects our commitment to translate scientific discovery into improved outcomes for patients.

  • Catalyze opportunities through the industry-inspired design of solutions for health problems associated with diabetes, cardiovascular disease and nutrition.
  • Complement and enhance the Indiana life sciences ecosystem by linking life science expertise to Hoosier health.
  • Connect industry, academia and the public sector to expedite solutions for the most pressing health issues related to cardio-metabolic diseases, including diabetes and poor nutrition.

View annual reports

2018 Annual Report cover

The IBRI 2018 Annual Report is now available. The report theme is “Discovery With Purpose,” which is also the IBRI’s motto as it reflects the Institute’s commitment to translating scientific discovery into improved outcomes for patients.